Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6274769 | 1.00 | FPR3 (0.38) | FPR3FPR2 | |
| SCHEMBL3983139 | 0.85 | FPR3 (0.34) | FPR3FPR2 | |
| SCHEMBL3989924 | 0.85 | FPR3 (0.34) | FPR3FPR2 | |
| SCHEMBL3983179 | 0.85 | FPR3 (0.34) | FPR3FPR2 | |
| SCHEMBL6809254 | 0.79 | CHRNB2 (0.35) | FPR3FPR2 | |
| SCHEMBL6267443 | 0.79 | CHRNB2 (0.35) | FPR3FPR2 | |
| SCHEMBL6810057 | 0.79 | CHRNB2 (0.35) | FPR3FPR2 | |
| SCHEMBL6268429 | 0.79 | EPHX1 (0.41) | — | |
| SCHEMBL3985896 | 0.76 | EPHX1 (0.36) | FPR3FPR2 | |
| SCHEMBL6710245 | 0.74 | EPHX1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040077618-A1 | Cycloalkylamides and their therapeutic applications | ABBOTT LABORATORIES | 2004-04-22 | — | — | US | claimed |
| US-20040077618-A1 | Cycloalkylamides and their therapeutic applications | ABBOTT LABORATORIES | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077618-A1 | Cycloalkylamides and their therapeutic applications | GAP43, SCN1B, GRIN2B | FPR3 503/4885FPR2 601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.